Indolizine: a biologically active moiety
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Wall, M. E., Wani, M. C., Cook, C. E., Palmer, K. H., McPhail, A. T., & Sim, G. A. (1966) · Journal of the American Chemical Society · doi:10.1021/ja00968a057 · Cited by 2,258
Tomlin, C. (2003) · Cited by 2,031
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487 · cited 1×
“…changes like heart disease and osteoporosis; Jorgensen et al. 2000a, claiming to be the first to report the synthesis of a non-steroidal full estrogen agonist, synthesized various pyrroloindolizine derivatives (Jorgensen et al., 2000b; Lobo, 1997; Colditz et al., 1995; Stanford et al., 1995).”
BackgroundThe role of natural product chemistry in drug discovery
Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Keynote review: Phosphodiesterase-4 as a therapeutic target
Houslay, M. D., Schafer, P., & Zhang, K. Y. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03622-6 · Cited by 635
Pyrimidine as Constituent of Natural Biologically Active Compounds
Lagoja, I. (2005) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490173 · Cited by 544
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
THE MAGIC BULLETS AND TUBERCULOSIS DRUG TARGETS
Zhang, Y. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100120 · Cited by 432
Hohenschutz, L. D., Bell, E. A., Jewess, P. J., Leworthy, D. P., Pryce, R. J., Arnold, E., & Clardy, J. (1981) · Phytochemistry · doi:10.1016/0031-9422(81)85181-3 · Cited by 383
Stanford, J. L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530020055032 · Cited by 339
Lee, W. S., Kanai, Y., Wells, R. G., & Hediger, M. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32677-7 · Cited by 268
Cloning and Characterization of Secretory Tyrosine Phosphatases of Mycobacterium tuberculosis
Koul, A., Choidas, A., Treder, M., Tyagi, A. K., Drlica, K., Singh, Y., & Ullrich, A. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.19.5425-5432.2000 · Cited by 181
Moore, M. H., Hunter, W. N., d'Estaintot, B. L., & Kennard, O. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90577-9 · Cited by 168
Baumer, W., Hoppmann, J., Rundfeldt, C., & Kietzmann, M. (2007) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152807780077318 · Cited by 162
Tissue-specific promoters regulate aromatase cytochrome P450 expression
Simpson, E. R., Mahendroo, M., Means, G., Kilgore, M. W., Corbin, C. J., & Mendelson, C. R. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90235-o · Cited by 146
3-Substituted indolizine-1-carbonitrile derivatives as phosphatase inhibitors
Weide, T., Arve, L., Prinz, H., Waldmann, H., & Kessler, H. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.09.051 · Cited by 145
Hori, K., & Saito, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601261 · Cited by 126
Sonnet, P., Dallemagne, P., Guillon, J., et al. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00024-9 · Cited by 125
Phosphatases and kinases delivered to the host cell by bacterial pathogens
DeVinney, R., Steele‐Mortimer, O., & Finlay, B. B. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(99)01657-1 · Cited by 110
James, D. A., Koya, K., Li, H., Liang, G., Xia, Z., Ying, W., Wu, Y., & Sun, L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.02.029 · Cited by 106
Mackenzie, B., Panayotova-Heiermann, M., Loo, D. D., Lever, J. E., & Wright, E. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31672-1 · Cited by 95
Phosphodiesterase-4 as a potential drug target
Zhang, K. Y. J., Ibrahim, P. N., Gillette, S., & Bollag, G. E. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.6.1283 · Cited by 85
Cesare, M. D., Pratesi, G., Perego, P., Carenini, N., Tinelli, S., Merlini, L., Penco, S., Pisano, C., Bucci, F., Vesci, L., et al. (2001) · PubMed · Cited by 68
Darwish, E. S. (2008) · Molecules · doi:10.3390/molecules13051066 · Cited by 66
Nihei, Y., Suga, Y., Morinaga, Y., Ohishi, K., Okano, A., Ohsumi, K., Hatanaka, T., Nakagawa, R., Tsuji, T., Akiyama, Y., et al. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00850.x · Cited by 58
Herbicidal indolizine‐5,8‐diones: photosystem I redox mediators
Smith, S. C., Clarke, E. D., Ridley, S. M., Bartlett, D., Greenhow, D. T., Glithro, H., Klong, A. Y., Mitchell, G., & Mullier, G. W. (2004) · Pest Management Science · doi:10.1002/ps.980 · Cited by 58
Shiose, Y., Ochi, Y., Kuga, H., Yamashita, F., & Hashida, M. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.2365 · Cited by 58
Kim, N. D., Park, E., Kim, Y. H., Moon, S. K., Lee, S. S., Ahn, S. K., Yu, D., No, K. T., & Kim, K. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.07.072 · Cited by 50
Bacopasaponin C: Critical Evaluation of Anti-Leishmanial Properties in Various Delivery Modes
Sinha, J., Raay, B., Das, N., Medda, S., Garai, S., Mahato, S. B., & Basu, M. K. (2002) · Drug Delivery · doi:10.1080/107175402753413181 · Cited by 49
Jørgensen, A. S., Jacobsen, P., Christiansen, L., Bury, P. S., Kanstrup, A., Thorpe, S. M., Bain, S., Nærum, L., & Wassermann, K. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00015-9 · Cited by 47
Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives
Jørgensen, A. S., Jacobsen, P., Christiansen, L. B., Bury, P. S., Kanstrup, A., Thorpe, S. M., Nærum, L., & Wassermann, K. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00474-1 · Cited by 46
Bloch, W. M., Derwent-Smith, S. M., Issa, F., Morris, J. C., Rendina, L. M., & Sumby, C. J. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.09.133 · Cited by 40
Lv, H., Ren, J., Ma, S., Xu, S., Qu, J., Liu, Z.-J., Zhou, Q., Chen, X., & Yu, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030342 · Cited by 35
Millet, R., Domarkas, J., Rigo, B., Goossens, L., Goossens, J., Houssin, R., & Hénichart, J. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00144-x · Cited by 28
Antimicrobial and Antimutagenic Properties of Newly Synthesized Derivatives of Indolizine
Olejníková (2009) · Scientia Pharmaceutica · doi:10.3797/scipharm.oephg.21.po-17 · Cited by 24
Ranga, R., Sharma, V., & Kumar, V. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0149-0 · Cited by 20
Self-citationSiegrist, R., Zürcher, M., Baumgartner, C., Seiler, P., Diederich, F., Daum, S., Fischer, G. S., Klein, C., Dangl, M., & Schwaiger, M. (2007) · Helvetica Chimica Acta · doi:10.1002/hlca.200790028 · Cited by 19
Shigemitsu, Y., Komiya, K., Mizuyama, N., & Tominaga, Y. (2008) · Journal of Molecular Structure THEOCHEM · doi:10.1016/j.theochem.2008.01.004 · Cited by 15
Clive, D. L. J., Yang, H., & Lewanczuk, R. Z. (2001) · Comptes Rendus de l Académie des Sciences - Series IIC - Chemistry · doi:10.1016/s1387-1609(01)01263-4 · Cited by 3
Cited by
Multicomponent syntheses of functional chromophores
Levi, L., & Müller, T. J. J. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00805k · Cited by 289
Metadata
- Authors
- Sharma, V., & Kumar, V.
- Venue
- Medicinal Chemistry Research
- Published
- 2014-02-27
- Volume
- 23
- Issue
- 8
- Pages
- 3593-3606
- ISSN
- 1054-2523 (ISSN-L)
- 1554-8120
- OpenAlex
- W2013554560
- Cited by
- 260
- References
- 41
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.